Lung and blood early biomarkers for host-directed tuberculosis therapies: Secondary outcome measures from a randomized controlled trial.

A trend toward a superior rate of reduction in CRP due to CC-11050 approached but did not reach statistical significance when analyzed according to the slope of log-log transformed values throughout treatment ( Table 4 ).

also in 111,027 other papers

Results All PET/CT parameters showed highly significant reductions from baseline to day 56; however, only maximal or peak glycolytic activity showed further experimental reduction compared to controls, and only in everolimus recipients.

also in 132,142 other papers